Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up

Rossi, 2008, The consensus statement on the locoregional treatment of abdominal sarcomatosis, J Surg Oncol, 98, 291, 10.1002/jso.21067 D'Angelo, 2010, Uterine sarcomas: a review, Gynecol Oncol, 116, 131, 10.1016/j.ygyno.2009.09.023 Zivanovic, 2009, Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems, J Clin Oncol, 27, 2066, 10.1200/JCO.2008.19.8366 Dinh, 2004, The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990–1999) at the Massachusetts General Hospital, Gynecol Oncol, 92, 648, 10.1016/j.ygyno.2003.10.044 Liu, 2015, A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature, Am J Obstet Gynecol, 10.1016/j.ajog.2015.01.012 Park, 2011, The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma, Gynecol Oncol, 122, 255, 10.1016/j.ygyno.2011.04.021 Jimenez, 2014, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent high-grade uterine sarcoma with peritoneal dissemination, Am J Obstet Gynecol, 210, 259, 10.1016/j.ajog.2013.11.002 Sommariva, 2013, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal sarcomatosis: long-term outcome from a single institution experience, Anticancer Res, 33, 3989 Baumgartner, 2013, Aggressive locoregional management of recurrent peritoneal sarcomatosis, J Surg Oncol, 107, 329, 10.1002/jso.23232 Salti, 2012, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis, Ann Surg Oncol, 19, 1410, 10.1245/s10434-012-2240-7 Kusamura, 2006, Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique, Cancer, 106, 1144, 10.1002/cncr.21708 Rossi, 2004, Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients, Cancer, 100, 1943, 10.1002/cncr.20192 Baratti, 2010, Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?, Ann Surg Oncol, 17, 3220, 10.1245/s10434-010-1178-x Walid, 2009, Use of bowel bags in gynecologic laparoscopy, Arch Gynecol Obstet, 279, 777, 10.1007/s00404-008-0923-x Oosten, 2009, Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine origin, Sarcoma, 348910 Ducoulombier, 2016, Gemcitabine-based chemotherapy in sarcomas: a systematic review of published trials, Crit Rev Oncol Hematol, 98, 73, 10.1016/j.critrevonc.2015.10.020 Randle, 2013, Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis, Am Surg, 79, 620, 10.1177/000313481307900624 Ducie, 2016, The role of adjuvant therapy in uterine leiomyosarcoma, Expert Rev Anticancer Ther, 16, 45, 10.1586/14737140.2016.1115724 Ricci, 2013, Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?, Gynecol Oncol, 131, 629, 10.1016/j.ygyno.2013.08.037 Mancari, 2014, Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients, Gynecol Oncol, 133, 531, 10.1016/j.ygyno.2014.03.001 Roque, 2016, Gemcitabine and docetaxel compared with observation, radiation, or other chemotherapy regimens as adjuvant treatment for stage I-to-IV uterine leiomyosarcoma, Int J Gynecol Cancer, 26, 505, 10.1097/IGC.0000000000000634 Hensley, 2013, Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005), Cancer, 119, 1555, 10.1002/cncr.27942 Greimel, 2011, Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of LifeQuestionnaire-Endometrial Cancer Module (EORTC QLQ-EN24), Eur J Cancer, 47, 183, 10.1016/j.ejca.2010.08.014 1990, EuroQol-a new facility for the measurement of health-related quality of life, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9 Raut, 2009, Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma, Eur J Cancer, 45, 2818, 10.1016/j.ejca.2009.06.030 Mowers, 2015, Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice, J Minim Invasive Gynecol, 22, 601, 10.1016/j.jmig.2015.01.007 Seidman, 2012, Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms, PLoS One, 7, e50058, 10.1371/journal.pone.0050058 Singh, 2015, Technical update on tissue morcellation during gynaecologic surgery: its uses, complications, and risks of unsuspected malignancy, J Obstet Gynaecol Can, 37, 68, 10.1016/S1701-2163(15)30366-2 Ip, 2010, Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy, Adv Anat Pathol, 17, 91, 10.1097/PAP.0b013e3181cfb901 Prat, 2009, FIGO staging for uterine sarcomas, Int J Gynaecol Obstet, 104, 177, 10.1016/j.ijgo.2008.12.008 Greene, 2012 Sharma, 2012, Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging, Nucl Med Commun, 33, 185, 10.1097/MNM.0b013e32834e41a6 Sadeghi, 2013, Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterinesarcomas: systematic review and meta-analysis of the literature, Int J Gynecol Cancer, 23, 1349, 10.1097/IGC.0b013e3182a20e18 Alessandria, 2015, Early stage endometrial cancer: laparoscopy vs laparotomy: IGCS-0081 uterine cancer, including sarcoma, Int J Gynecol Cancer, 25, 70 Macciò, 2016, Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures, Arch Gynecol Obstet, 10.1007/s00404-016-4075-0